z-logo
open-access-imgOpen Access
Dosing of Dolutegravir in TB/HIV Coinfected Patients on Rifampicin: Twice Is (Always) Better Than Once
Author(s) -
Dario Cattaneo,
Agostino Riva,
Paola Columpsi,
Giuseppe Lapadula,
Carlo Fı̀lice,
Cristina Gervasoni
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002352
Subject(s) - dolutegravir , dosing , rifampicin , medicine , human immunodeficiency virus (hiv) , virology , pharmacology , tuberculosis , antiretroviral therapy , viral load , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here